1. “Chemoimmunotherapy and radiation in pancreatic cancer (CRIT),” ClinicalTrials.gov. Identifier: NCT01903083.
2. “Pancreatic tumor cell vaccine (GVAX), low dose cyclophosphamide, fractionated stereotactic body radiation therapy (SBRT), and FOLFIRINOX chemotherapy in patients with resected adenocarcinoma of the pancreas,” ClinicalTrials.gov. Identifier: NCT01595321.
3. “Immune checkpoint inhibition (Tremelimumab and/or MEDI4736) in combination with radiation therapy in patients with unresectable pancreatic cancer,” ClinicalTrials.gov. Identifier: NCT02311361.
4. High-Resolution, Small Animal Radiation Research Platform With X-Ray Tomographic Guidance Capabilities